Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Naltrexone for Quality of Life in Multiple Sclerosis
NCT00501696Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Feb 2007
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone in multiple sclerosis (MS), sponsored by University of California, San Francisco. Started Feb 2007; status: completed.
02
Drugs
naltrexone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00501696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501696.